<DOC>
	<DOCNO>NCT00474708</DOCNO>
	<brief_summary>This study open-label , randomize , multi-center study conduct typical psychiatric outpatient practice China . This study intend collect data efficacy safety venlafaxine XR ( Efexor XR® ) versus SSRIs conventional antidepressant depress patient previously fail antidepressant treatment . This data use guide psychiatrist recommendation clinic use .</brief_summary>
	<brief_title>Study Comparing Efficacy Venlafaxine XR Vs. SSRIs Conventional Antidepressants Depressed Patients</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Main Males female , 18 65 year age Outpatients Major depressive disorder base DSMIV criteria The baseline score 17item HAMD³17 Switchers prior antidepressant , satisfactory improvement ( normally minimum 8weeks treatment ) , approve antidepressant medication experience intolerance due side effect antidepressant medication base clinical discretion Provide write informed consent If female childbearing potential , must confirm pregnancy baseline , use medically acceptable method contraception throughout study . Main Hypersensitivity venlafaxine ; Clinically significant renal hepatic disease medical disease , opinion investigator , might compromise study , include seizure Alcohol drug abuse within last year A recent history myocardial infarction unstable heart disease ( within 6 month baseline ) Bipolar disorder For female , know suspected pregnancy breast feeding Use monoamine oxidase inhibitor ( MAOI ) within 14 day baseline ; use investigational drug within 30 day baseline . Patients prior use venlafaxine use venlafaxine current episode .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>